Bernstein keeps USD 79 target for Centene stock

Published on 10/20/2026 at 21:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Centene reports third-quarter results October 27, 2026. Centene stock costs EUR 63.03 on October 20, 2026, up 4.04 percent versus the Xetra close.

Analyst target and reporting date

Bernstein maintained a USD 79.00 target for Centene on October 5, 2026.
Centene will publish third-quarter results on October 27, 2026.
Centene stock costs EUR 63.03 at Lang & Schwarz on October 20, 2026 at 9:49 p.m. CEST, 4.04 percent above the Xetra close of October 13, 2026.
Centene's market capitalization is USD 35.0 billion as of October 20, 2026.

CGI-Architekturrender eines modernen Pharmaunternehmens-Hauptquartiers mit Glasfassade — Cencora Inc. repräsentatives Glasgebäude US15135B1017 als realistisches CGI-Architektur-Render mit Spiegelteich und Parkanlage, Illustration mit AI erstellt.

Bernstein maintained a Buy rating and a USD 79.00 price target for Centene on October 5, 2026, according to Gekko. Centene stock was trading at EUR 63.03 at Lang & Schwarz on October 20, 2026 at 9:49 p.m. CEST, up 4.04 percent versus the Xetra close of October 13, 2026 at EUR 60.58.

Target leaves room above the stock

Bernstein's USD 79.00 target stands 11.52 percent above Centene's USD 70.84 primary-market price at 3:55 p.m. EDT on October 20, 2026. The comparison uses different currencies and therefore does not translate the target into the euro quotation.

The latest analyst overview listed six Buy ratings and nine Hold ratings among 15 firms, with a consensus target of USD 71.78. That target is 1.33 percent above the USD 70.84 primary-market price, while the Bernstein view is more optimistic.

What does the October 27 date mean?

Centene will release its 2026 third-quarter results at approximately 6:00 a.m. ET on October 27, 2026, followed by an 8:30 a.m. ET earnings call, the company said in a release carried by Centene on October 19, 2026. The scheduled report is the next dated company event.

Second-quarter figures set the comparison

Centene reported second-quarter 2026 revenue of USD 53.58 billion, up 9.90 percent from the prior-year quarter, while adjusted earnings per share reached USD 2.51 versus a USD 1.09 consensus estimate. Zacks reported the figures and said premium and service revenue reached USD 43.60 billion, up 4.40 percent year over year.

Valuation and market position

Centene's market capitalization was USD 35.0 billion on October 20, 2026. Its USD 31.63 to USD 71.21 52-week range places the USD 70.84 primary-market price 0.52 percent below the high. Centene's year-to-date gain was 69.70 percent in the same market snapshot, while trading volume reached 2,390,714 shares against an average of 4,591,734.

Comparison with peers

Centene Corp.: 3.22 percent higher on October 20, 2026, negative trailing P/E, market capitalization USD 35.0 billion.

UnitedHealth Group (NYSE, USD): 1.40 percent higher, P/E 23.24, market capitalization USD 365.31 billion.

Humana (NYSE, USD): 0.50 percent higher, P/E 39.29, market capitalization USD 49.87 billion.

Stock position after hours

Centene's euro quotation was 4.04 percent above the Xetra close of October 13, 2026, while its primary-market price sat 0.52 percent below the 52-week high. The next major company date is October 27, 2026.

The further course of trading is shown by the continuously updated real-time quote of Centene stock.